Copyright Reports & Markets. All rights reserved.

Global Coronary Intervention Drug Eluting Stent Market Research Report 2021

Request for Sample of this report
Buy now

1 Coronary Intervention Drug Eluting Stent Market Overview

  • 1.1 Product Overview and Scope of Coronary Intervention Drug Eluting Stent
  • 1.2 Coronary Intervention Drug Eluting Stent Segment by Type
    • 1.2.1 Global Coronary Intervention Drug Eluting Stent Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Below 40 µm
    • 1.2.3 40 µm- 65 µm
    • 1.2.4 Above 65 µm
  • 1.3 Coronary Intervention Drug Eluting Stent Segment by Application
    • 1.3.1 Coronary Intervention Drug Eluting Stent Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Global Coronary Intervention Drug Eluting Stent Market Size Estimates and Forecasts
    • 1.4.1 Global Coronary Intervention Drug Eluting Stent Revenue 2016-2027
    • 1.4.2 Global Coronary Intervention Drug Eluting Stent Sales 2016-2027
    • 1.4.3 Coronary Intervention Drug Eluting Stent Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coronary Intervention Drug Eluting Stent Market Competition by Manufacturers

  • 2.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Coronary Intervention Drug Eluting Stent Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Coronary Intervention Drug Eluting Stent Manufacturing Sites, Area Served, Product Type
  • 2.5 Coronary Intervention Drug Eluting Stent Market Competitive Situation and Trends
    • 2.5.1 Coronary Intervention Drug Eluting Stent Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Coronary Intervention Drug Eluting Stent Players Market Share by Revenue
    • 2.5.3 Global Coronary Intervention Drug Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coronary Intervention Drug Eluting Stent Retrospective Market Scenario by Region

  • 3.1 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Coronary Intervention Drug Eluting Stent Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
    • 3.3.1 North America Coronary Intervention Drug Eluting Stent Sales by Country
    • 3.3.2 North America Coronary Intervention Drug Eluting Stent Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
    • 3.4.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country
    • 3.4.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Coronary Intervention Drug Eluting Stent Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Coronary Intervention Drug Eluting Stent Sales by Region
    • 3.5.2 Asia Pacific Coronary Intervention Drug Eluting Stent Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
    • 3.6.1 Latin America Coronary Intervention Drug Eluting Stent Sales by Country
    • 3.6.2 Latin America Coronary Intervention Drug Eluting Stent Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Coronary Intervention Drug Eluting Stent Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Coronary Intervention Drug Eluting Stent Sales by Country
    • 3.7.2 Middle East and Africa Coronary Intervention Drug Eluting Stent Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Type

  • 4.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)
  • 4.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)
  • 4.3 Global Coronary Intervention Drug Eluting Stent Price by Type (2016-2021)

5 Global Coronary Intervention Drug Eluting Stent Historic Market Analysis by Application

  • 5.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)
  • 5.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2016-2021)
  • 5.3 Global Coronary Intervention Drug Eluting Stent Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Synlas GmbH
    • 6.1.1 Synlas GmbH Corporation Information
    • 6.1.2 Synlas GmbH Description and Business Overview
    • 6.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Synlas GmbH Product Portfolio
    • 6.1.5 Synlas GmbH Recent Developments/Updates
  • 6.2 YILSON
    • 6.2.1 YILSON Corporation Information
    • 6.2.2 YILSON Description and Business Overview
    • 6.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 YILSON Product Portfolio
    • 6.2.5 YILSON Recent Developments/Updates
  • 6.3 BrosMed Medical
    • 6.3.1 BrosMed Medical Corporation Information
    • 6.3.2 BrosMed Medical Description and Business Overview
    • 6.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 BrosMed Medical Product Portfolio
    • 6.3.5 BrosMed Medical Recent Developments/Updates
  • 6.4 SCITECH Medical
    • 6.4.1 SCITECH Medical Corporation Information
    • 6.4.2 SCITECH Medical Description and Business Overview
    • 6.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 SCITECH Medical Product Portfolio
    • 6.4.5 SCITECH Medical Recent Developments/Updates
  • 6.5 Wellinq
    • 6.5.1 Wellinq Corporation Information
    • 6.5.2 Wellinq Description and Business Overview
    • 6.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Wellinq Product Portfolio
    • 6.5.5 Wellinq Recent Developments/Updates
  • 6.6 Degania Silicone
    • 6.6.1 Degania Silicone Corporation Information
    • 6.6.2 Degania Silicone Description and Business Overview
    • 6.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Degania Silicone Product Portfolio
    • 6.6.5 Degania Silicone Recent Developments/Updates
  • 6.7 Alvimedica
    • 6.6.1 Alvimedica Corporation Information
    • 6.6.2 Alvimedica Description and Business Overview
    • 6.6.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Alvimedica Product Portfolio
    • 6.7.5 Alvimedica Recent Developments/Updates
  • 6.8 Interventional Medical Device Solutions
    • 6.8.1 Interventional Medical Device Solutions Corporation Information
    • 6.8.2 Interventional Medical Device Solutions Description and Business Overview
    • 6.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Interventional Medical Device Solutions Product Portfolio
    • 6.8.5 Interventional Medical Device Solutions Recent Developments/Updates
  • 6.9 Comed BV
    • 6.9.1 Comed BV Corporation Information
    • 6.9.2 Comed BV Description and Business Overview
    • 6.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Comed BV Product Portfolio
    • 6.9.5 Comed BV Recent Developments/Updates
  • 6.10 iVascular
    • 6.10.1 iVascular Corporation Information
    • 6.10.2 iVascular Description and Business Overview
    • 6.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 iVascular Product Portfolio
    • 6.10.5 iVascular Recent Developments/Updates
  • 6.11 LEPU Medical
    • 6.11.1 LEPU Medical Corporation Information
    • 6.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 LEPU Medical Product Portfolio
    • 6.11.5 LEPU Medical Recent Developments/Updates
  • 6.12 Eurocor Tech GmbH
    • 6.12.1 Eurocor Tech GmbH Corporation Information
    • 6.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Eurocor Tech GmbH Product Portfolio
    • 6.12.5 Eurocor Tech GmbH Recent Developments/Updates
  • 6.13 OrbusNeich
    • 6.13.1 OrbusNeich Corporation Information
    • 6.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 OrbusNeich Product Portfolio
    • 6.13.5 OrbusNeich Recent Developments/Updates
  • 6.14 Endocor GmbH
    • 6.14.1 Endocor GmbH Corporation Information
    • 6.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Endocor GmbH Product Portfolio
    • 6.14.5 Endocor GmbH Recent Developments/Updates
  • 6.15 Meril Life Sciences
    • 6.15.1 Meril Life Sciences Corporation Information
    • 6.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Meril Life Sciences Product Portfolio
    • 6.15.5 Meril Life Sciences Recent Developments/Updates
  • 6.16 Acrostak
    • 6.16.1 Acrostak Corporation Information
    • 6.16.2 Acrostak Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Acrostak Product Portfolio
    • 6.16.5 Acrostak Recent Developments/Updates
  • 6.17 Boston Scientific Corporation
    • 6.17.1 Boston Scientific Corporation Corporation Information
    • 6.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Boston Scientific Corporation Product Portfolio
    • 6.17.5 Boston Scientific Corporation Recent Developments/Updates
  • 6.18 B. Braun
    • 6.18.1 B. Braun Corporation Information
    • 6.18.2 B. Braun Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 B. Braun Product Portfolio
    • 6.18.5 B. Braun Recent Developments/Updates
  • 6.19 Biotronik
    • 6.19.1 Biotronik Corporation Information
    • 6.19.2 Biotronik Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Biotronik Product Portfolio
    • 6.19.5 Biotronik Recent Developments/Updates
  • 6.20 Abbott
    • 6.20.1 Abbott Corporation Information
    • 6.20.2 Abbott Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Abbott Product Portfolio
    • 6.20.5 Abbott Recent Developments/Updates
  • 6.21 MicroPort Medical Group
    • 6.21.1 MicroPort Medical Group Corporation Information
    • 6.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 MicroPort Medical Group Product Portfolio
    • 6.21.5 MicroPort Medical Group Recent Developments/Updates
  • 6.22 Philips
    • 6.22.1 Philips Corporation Information
    • 6.22.2 Philips Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Philips Product Portfolio
    • 6.22.5 Philips Recent Developments/Updates
  • 6.23 Terumo Corporation
    • 6.23.1 Terumo Corporation Corporation Information
    • 6.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Description and Business Overview
    • 6.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Terumo Corporation Product Portfolio
    • 6.23.5 Terumo Corporation Recent Developments/Updates

7 Coronary Intervention Drug Eluting Stent Manufacturing Cost Analysis

  • 7.1 Coronary Intervention Drug Eluting Stent Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Coronary Intervention Drug Eluting Stent
  • 7.4 Coronary Intervention Drug Eluting Stent Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Coronary Intervention Drug Eluting Stent Distributors List
  • 8.3 Coronary Intervention Drug Eluting Stent Customers

9 Coronary Intervention Drug Eluting Stent Market Dynamics

  • 9.1 Coronary Intervention Drug Eluting Stent Industry Trends
  • 9.2 Coronary Intervention Drug Eluting Stent Growth Drivers
  • 9.3 Coronary Intervention Drug Eluting Stent Market Challenges
  • 9.4 Coronary Intervention Drug Eluting Stent Market Restraints

10 Global Market Forecast

  • 10.1 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Type (2022-2027)
  • 10.2 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Application (2022-2027)
  • 10.3 Coronary Intervention Drug Eluting Stent Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Coronary Intervention Drug Eluting Stent by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Coronary Intervention Drug Eluting Stent by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Below 40 µm
    40 µm- 65 µm
    Above 65 µm

    Segment by Application
    Hospital
    Clinic
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Synlas GmbH
    YILSON
    BrosMed Medical
    SCITECH Medical
    Wellinq
    Degania Silicone
    Alvimedica
    Interventional Medical Device Solutions
    Comed BV
    iVascular
    LEPU Medical
    Eurocor Tech GmbH
    OrbusNeich
    Endocor GmbH
    Meril Life Sciences
    Acrostak
    Boston Scientific Corporation
    B. Braun
    Biotronik
    Abbott
    MicroPort Medical Group
    Philips
    Terumo Corporation

    Buy now